Expertise in
19
conditions
Expertise in
19
conditions

Overview

Stanton Goldman is a Pediatric Hematologist Oncology specialist and a Pediatrics provider in Mt Pleasant, Texas. Dr. Goldman is highly rated in 19 conditions, according to our data. His top areas of expertise are Langerhans Cell Histiocytosis, Histiocytosis, Reticulohistiocytoma, Ewing Sarcoma, and Bone Marrow Aspiration.

His clinical research consists of co-authoring 16 peer reviewed articles and participating in 51 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatric Hematology Oncology
Pediatrics
Licenses
Pediatric Hematology-Oncology in TX
Languages Spoken
English
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Cigna
  •  Friday Health
  •  Scott and White Health
  •  UnitedHealthcare
  •  Oscar
  •  Humana

Locations

TEXAS ONCOLOGY PA
2001 N Jefferson Ave, Suite 300, Mt Pleasant, TX 75455
903-566-4429

Additional Areas of Focus

Dr. Goldman has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


51 Clinical Trials

A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (IND# 133688, NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A(MLL) Gene Rearrangement
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
A Phase 3 Randomized Trial for Patients With De Novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 With GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients With FLT3 Mutations
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic Chemotherapy Backbones
Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
A Phase 2 Randomized Study of Irinotecan/Temozolomide/Dinutuximab With or Without Eflornithine (DFMO) in Children With Relapsed, Refractory or Progressive Neuroblastoma
A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or ALK Inhibitor Therapy Added to Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
A Phase III Study for Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide and All-Trans Retinoic Acid
A Phase 2 Study of Blinatumomab (NSC# 765986) in Combination With Nivolumab (NSC # 748726), a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged >/= 1 to < 31 Years Old With First Relapse
LEAHRN (Late Effects After High-Risk Neuroblastoma) Study
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
View 49 Less Clinical Trials
Similar Doctors
Expertise in
4
conditions
Pain Medicine | Physiatry | Pediatrics
Expertise in
4
conditions
Pain Medicine | Physiatry | Pediatrics

Regional Clinics Of Longview

709 Hollybrook Dr, Suite 5601, 
Longview, TX 
 (46.6 mi)
Languages Spoken:
English

Matthew Porter is a Pain Medicine specialist and a Physiatrist in Longview, Texas. Dr. Porter is highly rated in 4 conditions, according to our data. His top areas of expertise are Sacroiliac Joint Disease, Spinal Stenosis, Cervical Spondylosis, and Chronic Pain.

Expertise in
2
conditions
Pediatrics | Hospital Medicine
Expertise in
2
conditions
Pediatrics | Hospital Medicine

Pittsburg Hospital LLC

2701 Us Hwy 271 N, 
Pittsburg, TX 
 (9.9 mi)
Languages Spoken:
English

Gregory Zarcone is a Pediatrics specialist and a Hospital Medicine provider in Pittsburg, Texas. Dr. Zarcone is highly rated in 2 conditions, according to our data. His top areas of expertise are Acute Pancreatitis, Multisystem Inflammatory Syndrome in Children (MIS-C), Hereditary Pancreatitis, Hernia Surgery, and Hip Replacement.

Expertise in
2
conditions
Pediatrics | Internal Medicine
Expertise in
2
conditions
Pediatrics | Internal Medicine

Christus Trinity Clinic

630 S Fleishel Ave, 
Tyler, TX 
 (60.4 mi)
Languages Spoken:
English
Accepting New Patients

Tiffany Egbe is a Pediatrics specialist and an Internal Medicine provider in Tyler, Texas. Dr. Egbe is highly rated in 2 conditions, according to our data. Her top areas of expertise are Sickle Cell Disease, Sepsis, Gastrointestinal Bleeding, Gastrostomy, and Endoscopy. Dr. Egbe is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile